Literature DB >> 30090426

Cisplatin nephrotoxicity in male beagle dogs: next-generation protein kidney safety biomarker tissue expression and related changes in urine.

J E McDuffie1, Y Chen1, J Y Ma1, S Lee1, K M Lynch2, D M Hamlin3, L Nguyen1, M Rizzolio1, M Sonee4, S Snook1.   

Abstract

This 10-day (D) study was conducted to evaluate changes in traditional and newer kidney safety biomarker expression levels in dogs. Animals received cisplatin (CDDP, 0.75 mg per kg per day) or 0.9% Saline (vehicle) for 5 days. Serum/urine samples were collected at various time points. Cage-side observations included emesis (D1-2/D4-D5/D7-9), absence of stool (D5-9/D11), soft stool (D4-7/D12), excessive salivation (D1/D3/D5-6), decreased food consumption (D5-8), decreased activity (D7-8) and/or dehydration (D7). Animals were necropsied when serum creatinine (sCr) levels measured at ≥1.9 mg dL-1, indicating significant loss of renal function; or at the end of the study (D11). When compared to controls, increases in BUN/sCr were detected on D3, D5 and/or D8. Increases in urinary total protein (Ur TP) were noted on D6. The moribund dog that was euthanized early on D7 showed insignificant increases in urinary osteopontin (Ur OPN), urinary neutrophil gelatinase-associated lipocalin (Ur NGAL), urinary clusterin (Ur CLU), sCr, serum cystatin C (sCYS C) and urinary cystatin C (Ur CYS C) on D5 when compared to controls. Insignificant increases in urinary albumin (Ur ALB) were observed from an animal that was euthanized on D7 and 1 : 2 surviving animals on D8 relative to baseline. From three dogs that were euthanized on D9, increases in Ur CLU, and/or sCYS C were noted on D8 relative to baseline. The two surviving dogs showed elevated Ur CLU and 1 : 2 surviving dogs showed elevated Ur CYS C. Decreased urinary kidney injury molecule 1 (Ur KIM-1) on D3/D5 was evident (versus baseline and controls). CDDP-induced cortico-medullary lesions were characterized as minimal to mild tubule degeneration/necrosis, dilatation, regeneration, cell alteration, intratubular casts, interstitial inflammation and vacuolization. Increased Ur OPN and Ur CLU correlated with enhanced OPN and CLU immunopositive staining in damaged cortical epithelium in the proximal tubules. Enhanced KIM-1 staining in damaged cortico-medullary tubular epithelium appeared in the absence of rises in Ur KIM-1. This study showed changes in kidney safety protein biomarkers associated with CDDP nephrotoxicity in dogs and possibly in humans.

Entities:  

Year:  2016        PMID: 30090426      PMCID: PMC6062370          DOI: 10.1039/c5tx00497g

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  46 in total

1.  Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics.

Authors:  Deborah Burt; Sarah J Crowell; David C Ackley; Thomas V Magee; Jiri Aubrecht
Journal:  Drug Chem Toxicol       Date:  2013-10-16       Impact factor: 3.356

2.  Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

Authors:  T Ichimura; J V Bonventre; V Bailly; H Wei; C A Hession; R L Cate; M Sanicola
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

3.  Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process.

Authors:  Y Xie; S Nishi; S Iguchi; N Imai; M Sakatsume; A Saito; M Ikegame; N Iino; H Shimada; M Ueno; H Kawashima; M Arakawa; F Gejyo
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

Review 4.  Urinary biomarkers for acute kidney injury in dogs.

Authors:  J De Loor; S Daminet; P Smets; B Maddens; E Meyer
Journal:  J Vet Intern Med       Date:  2013-08-19       Impact factor: 3.333

5.  Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.

Authors:  Rebecca M Wadey; Mark G Pinches; Huw B Jones; Daniela Riccardi; Sally A Price
Journal:  Toxicol Pathol       Date:  2013-07-03       Impact factor: 1.902

6.  Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin.

Authors:  Jean-Charles Gautier; Björn Riefke; Jakob Walter; Petra Kurth; Lou Mylecraine; Valérie Guilpin; Norman Barlow; Thierry Gury; David Hoffman; Daniela Ennulat; Kerstin Schuster; Ernie Harpur; Syril Pettit
Journal:  Toxicol Pathol       Date:  2010-08-17       Impact factor: 1.902

Review 7.  Urinary protein and enzyme excretion as markers of tubular damage.

Authors:  Giuseppe D'Amico; Claudio Bazzi
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-11       Impact factor: 2.894

8.  Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity.

Authors:  John W Davis; Federico M Goodsaid; Christopher M Bral; Leslie A Obert; George Mandakas; C Edwin Garner; Nathaniel D Collins; Roger J Smith; I Y Rosenblum
Journal:  Toxicol Appl Pharmacol       Date:  2004-10-01       Impact factor: 4.219

9.  Relation of preclinical toxicology to findings in early clinical trials.

Authors:  C K Grieshaber; S Marsoni
Journal:  Cancer Treat Rep       Date:  1986-01

Review 10.  Pathophysiology of proteinuria.

Authors:  Giuseppe D'Amico; Claudio Bazzi
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

View more
  1 in total

Review 1.  The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Smaranda Radu; Claudia Florida Costea; Manuela Ciocoiu; Alexandru Carauleanu; Cristina Mihaela Lacatusu; Minela Aida Maranduca; Mariana Floria; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2019-10-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.